The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.
Almost twice as many drugs for neglected diseases have received regulatory approval around the world over the past few years compared with the beginning of the last decade, according to a new study.
A bill passed in the Senate will provide measures to speed up the development of treatments for people who desperately need them.
A subsidiary of Aceto Corp. has launched two generic drugs for treating infectious diseases, the company said Monday.
A vaccine for the mosquito-borne illness dengue fever is in the final stages of development,...